Effect of Probiotics on Stress in Young Adults
1 other identifier
interventional
240
1 country
1
Brief Summary
The study investigates the effects of probiotics in a young healthy population experiencing stress during a stress challenge, i.e. The Trier Social Stress Test (TSST).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2023
CompletedStudy Start
First participant enrolled
April 5, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2023
CompletedDecember 15, 2023
December 1, 2023
8 months
March 29, 2023
December 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perceived stress
Change in Perceived Stress Visual Analog Scale (VAS) in response to TSST
Before, during, and after TSST at visit 2 (week 8)
Secondary Outcomes (6)
STAI score
Before and after TSST at visit 2 (week 8)
PSS score
baseline and week 8
STAI score
baseline and week 8
Anxiety
Before, during, and after TSST at visit 2 (week 8)
Emotional insecurity
Before, during, and after TSST at visit 2 (week 8)
- +1 more secondary outcomes
Other Outcomes (3)
Cortisol
Before, during, and after TSST at visit 2 (week 8)
Inflammatory biomarker IL-6
baseline and week 8
Inflammatory biomarker IL-10
baseline and week 8
Study Arms (3)
Probiotics combined strains
EXPERIMENTALProbiotics combined strains administered as oral capsules once daily
Probiotics single strain
EXPERIMENTALProbiotics single strain administered as oral capsules once daily
Placebo
PLACEBO COMPARATORPlacebo capsule administered orally once daily
Interventions
Eligibility Criteria
You may qualify if:
- Able to give informed e-consent
- Be between 18 and 45 years old, inclusive
- In general good health, as determined by the investigator
- Have a BMI of ≥18.5 and \<30.0 kg/m2
- Willing to consume the study product daily for the duration of the study and comply with the study procedures
- Have moderate stress, as measured on the Cohen's Perceived Stress Scale, with a score between 14 and 26 (inclusive)
- Be able to communicate well with the Investigator, to understand and comply with the study requirements and be judged suitable for the study in the opinion of the investigator
You may not qualify if:
- Scores ≥10 on General Anxiety Disorder 7 item (GAD-7) and Patient Health Questionnaire 9 item (PHQ-9)
- Have a history of in-person public speaking or presenting to large groups regularly (≥2 times/year) in the past 12 months
- Have a known major stressful life event occurring (current or upcoming) during the study
- Participants who have a significant illness or condition which may, in the opinion of the investigator impact their ability to participate in the study or impact the study outcomes (e.g. any chronic disease, including hypertension, type 1 or 2 diabetes, cardiovascular diseases, gastrointestinal disorders, celiac disease, and IBD)
- Any disease, that by the investigator's judgement, could interfere with the intestinal barrier function
- Use of oral or systemic (topical allowed) immunosuppressant drugs, antibiotics, steroids, etc. within the one month before screening
- Consumption of probiotic supplements that contain live bacteria in the 4 weeks before the screening
- Regular use of anti-inflammatory drugs such as aspirin or ibuprofen (\>200mg/24 hours)
- Food allergy or hypersensitivity to any component of the product
- Heavy alcohol use or recent history (within one year) of illicit drug use
- Participants who work night shifts
- Participation in other clinical trials or studies in the last month
- Desire and/or plans on changing current diet and/or exercise regime during the participation of this study
- Participants who are pregnant or wish to become pregnant during the study
- Participants who are lactating and/or currently breastfeeding
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chr Hansenlead
Study Sites (1)
Atlantia clinical trials
Cork, Ireland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Timothy Dinan, Professor
Atlantia Clinical Trials Ltd
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2023
First Posted
May 3, 2023
Study Start
April 5, 2023
Primary Completion
December 11, 2023
Study Completion
December 11, 2023
Last Updated
December 15, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share